论文部分内容阅读
目的分析乙型病毒性肝炎各临床分型的住院费用与影响因素。方法通过收集一家哨点医院2009-2010年病案系统数据,对多种乙型肝炎临床分型的病案数据汇总,运用SPSS15.0对病例流行病学特征和住院费用进行分析。结果 2009-2010年共监测乙型病毒性肝炎以及相关住院病例共2 765例,病例主要缴费方式以社会医疗保险为主;平均住院天数为(13.6±2.0)d;住院肝炎病例人均总住院费用几何均数(9 963.63±2.10)元,日均总费用的几何均数为(732.16±1.51)元,急性乙肝的住院费用和日均住院费用均比慢性肝高,日均住院费用则为肝硬化伴食管静脉曲张病例>肝硬化病例>肝纤维化病例,肝癌病例的住院费用和日均住院费用均高于其它临床分型;西药费、化验费和诊疗费在总费用中所占比例较大;高年龄、住院天数多、病情较重、合并其它肝脏疾病、手术和自费缴费均提高总住院费用。结论加强疫苗接种,特别是阻断母婴传播和幼儿感染,降低慢性化,对重点人群开展综合监测和预防控制是深圳未来降低肝炎疾病和经济负担的重要手段。
Objective To analyze the hospitalization costs and influential factors of each clinical type of hepatitis B virus infection. Methods By collecting the data of the case record system from 2009 to 2010 in a sentinel hospital, the data of various types of hepatitis B cases were collected. The epidemiological characteristics and hospitalization costs of the cases were analyzed by SPSS15.0. Results A total of 2 765 cases of hepatitis B and related hospitalizations were monitored during 2009-2010. The main payment methods were social medical insurance, the average length of stay was (13.6 ± 2.0) days, and the average hospitalization cost per hospitalized hepatitis The average geometric mean (9 963.63 ± 2.10) yuan, the average daily total cost of the geometric mean was (732.16 ± 1.51) yuan, acute hepatitis B hospitalization costs and daily hospitalization costs were higher than the chronic liver, liver disease, average daily hospitalization costs for the liver Sclerosis with esophageal varices cases> Cirrhosis cases> Liver fibrosis cases, liver cancer cases hospitalization costs and daily hospitalization costs were higher than other clinical types; western medicine costs, laboratory costs and medical expenses in the total cost of the proportion of Large; high age, hospitalization days, serious condition, the merger of other liver diseases, surgery and self-payment are to raise the total cost of hospitalization. CONCLUSIONS: Strengthening vaccination, in particular blocking mother-to-child transmission and young children’s infection, decreasing chronicity and comprehensive monitoring and prevention and control of key populations are important means to reduce the hepatitis disease and economic burden in Shenzhen in the future.